In this unique and exclusive opportunity, you'll watch and listen to an expert panel of haematologists challenge the existing mindsets around haemophilia care and explore a new standard of care in haemophilia to normalise haemostasis.

We invite you to watch the panel discussion and take an assessment to explore your thoughts on the approach to managing patients with haemophilia.

 

Will the expert panel change your own mind on haemophilia management?

 

This educational programme will help you understand more about:

  • The potential to normalise haemostasis as a new clinical concept in the care of patients with haemophilia A 

  • The impact of the rapidly changing therapeutic landscape for haemophilia A on the day-to-day care of patients with haemophilia, treatment goals and outcomes and the overall daily lives of patients

  • How to elevate the standard of care in haemophilia A

 

Clinical Takeaways

  • Normalising haemostasis is a realistic and appropriate aspiration for patients, and new medication is a prerequisite for this concept

  • Normalising haemostasis is more than just zero bleeds

  • Normalising haemostasis as a treatment goal is adaptable for all stages of life

Pål Andrè Holme is Professor of Haematology and Senior Haematologist at the Department of Haematology and Institute of Clinical Medicine, Oslo University and Oslo University Hospital, Rikshospitalet, Norway. He graduated from the Medical School at the University of Oslo in 1993 and was a research fellow at the Institute for Internal Medicine, University of Oslo, where he earned a PhD in 1996 after studies on platelet activation and platelet-derived-microparticle formation. He is a specialist in internal medicine and haematology. Prof. Holme has been responsible for the treatment of adult patients with haemophilia and bleeding related disorders in Norway since 2006. He leads a research group at Institute of Clinical Medicine and participates in several clinical research groups and has for a long time been an active investigator in studies on bleeding related disorders and platelets, and has authored many papers published in peer-reviewed journals and textbook chapters on these subjects.

Prof. Pål Andrè Holme has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Bayer, Octopharma, Pfizer, Sobi and Takeda. 

Prof Niamh O’Connell is a Consultant Haematologist at the National Coagulation Centre (NCC), St. James’s Hospital, Dublin, Ireland and has taken on the role of National Haemophilia Director since early 2018. The NCC is the lead comprehensive care centre for adults in Ireland and provides a hub of clinical services, research, training and education on a national basis. The NCC, in partnership with the Irish Haemophilia Society, is committed to delivering high quality and safe healthcare and to promoting healthy and successful living for people and their families living with haemophilia and other coagulation disorders. Research interests include clinical trials in novel therapies for haemophilia, clinical outcomes in haemophilia and application of information technology solutions in the management of haemophilia.

Jan Blatný, MD, PhD, is Consultant Haematologist at the Department of Paediatric Haematology and Biochemistry, Centre for Thrombosis and Haemostasis and the Director of the Haemophilia Comprehensive Care Centre of University Hospital in Brno, Czech Republic. He is also an Associate Professor of Paediatrics at Masaryk University in Brno, Czech Republic. His research interests encompass paediatric haematology, thrombosis and haemostasis, and life-threatening bleeding. He is a member of the Working Party on population PK of the ISTH SSC Subcommittee on Factor VIII and IX and Rare Bleeding Disorders. In addition to ISTH, Dr Blatný is a member of numerous national and international haematology organizations. He serves on the steering committee and is a paediatric coordinator of the Czech National Haemophilia Programme, Vice-president and a member of Executive Committee of EAHAD, member of MAG (Medical advisory group) of EHC, a reviewer for several haematology journals, and is on the editorial board for an official journal of Czech Haematology society. Dr Blatný’s publication credits are 9 book chapters and over 100 articles published in peer-reviewed journals

Assoc. Prof. Jan Blatný has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Novo Nordisk, Pfizer, Roche, Sobi and Takeda. 

Programme summary
Take the e-learning now
Share this programme
This educational programme is supported by an Independent Educational Grant from Sobi.
Accreditation
EACCME
This course has been accredited by EACCME® for 1 ECMEC®.
I agree that this educational programme:

Was valuable to me

1/4

Other programmes of interest

podcast Podcast

Episode

2

of 2

episode
Hemostasis and bleeding disorders 
Thrombophilia testing: Who to test and when?

Episode 2 - Medical experts discuss the controversies around thrombophilia testing, review the current ASH guidelines and share their views on best practice

Experts
Prof. Saskia Middeldorp, Prof. Jean Connors
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2024

Educational programme supported by an Independent Educational Grant from Pentapharm
podcast Podcast

Episode

1

of 2

episode
Hemostasis and bleeding disorders 
Thrombophilia: Clinical overview and impact on patients

Episode 1 - Experts discuss the main causes and symptoms of thrombophilia, and potential implications for the patient

Experts
Prof. Cedric Hermans, Prof. Sabine Eichinger
  • download Downloadable
    Resources
  • clock MIN
  • calendar Feb 2024

Educational programme supported by an Independent Educational Grant from Pentapharm.
video Video
Hemostasis and bleeding disorders 
MOVE Haemophilia 2023

Implementing international guidelines and best practices for hemophilia in clinical practice

Experts
Prof. Ana Boban, Dr Christoph Königs, Prof. Jan Astermark, Prof. Pratima Chowdary, Dr Steven Kitchen, Dr Sebastien Lobet
  • download Downloadable
    Resources
  • clock 15 MIN
  • calendar Dec 2023

Educational programme supported by an Independent Educational Grant from Sobi.
podcast Podcast
Rare diseases Hemostasis and bleeding disorders 
Rare diseases: gene therapy and gene-modified cell therapies

Current role, potential and the example of hemophilia

Experts
Prof. Cedric Hermans, Prof. Miguel Escobar
  • download Downloadable
    Resources
  • clock MIN
  • calendar Dec 2023

Educational programme supported by an Independent Educational Grant from American Society of Gene + Cell Therapy and Pfizer.
podcast Podcast

Episode

4

of 4

episode
Hemostasis and bleeding disorders 
Perioperative thromboprophylaxis revisited

Minimising the risk of thrombosis in surgical patients

Experts
Prof. Dimitrios Tsakiris, Prof. Daniel Bolliger
  • download Downloadable
    Resources
  • clock MIN
  • calendar Nov 2023

Educational programme supported by an Independent Educational Grant from Viatris.
podcast Podcast

Episode

3

of 4

episode
Hemostasis and bleeding disorders 
VTE: What is the optimal duration of antithrombotic treatment?

Part 3 of a 4-part series on thrombosis

Experts
Prof. Dimitrios Tsakiris, Prof. Jerzy Windyga
Endorsed by
Fundacja Trombofilia i Zakrzepica
  • download Downloadable
    Resources
  • clock MIN
  • calendar Oct 2023

Educational programme supported by an Independent Educational Grant from Viatris.